Skip to main navigation Skip to search Skip to main content

Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene

  • Xianming Wang
  • , Shen Chen
  • , Ingo Burtscher
  • , Michael Sterr
  • , Anja Hieronimus
  • , Fausto Machicao
  • , Harald Staiger
  • , Hans Ulrich Häring
  • , Gabriele Lederer
  • , Thomas Meitinger
  • , Heiko Lickert
  • Helmholtz Zentrum München German Research Center for Environmental Health
  • Technical University of Munich
  • Zhongshan School of Medicine, SYSU
  • University of Tübingen
  • German Centre for Diabetes Research (DZD)

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Homozygous loss-of-function mutations in the gene coding for the homeobox transcription factor PDX1 leads to pancreatic agenesis, whereas certain heterozygous point mutations are associated with Maturity-Onset Diabetes of the Young 4 (MODY4) and Type 2 Diabetes Mellitus (T2DM). To understand the pathomechanism of MODY4 and T2DM, we have generated iPSCs from a woman with a P33T heterozygous mutation in the transactivation domain of PDX1. The resulting PDX1 P33T iPSCs generated by episomal reprogramming are integration-free, have a normal karyotype and are pluripotent in vitro and in vivo. Taken together, this iPSC line will be useful to study diabetes pathomechanisms.

Original languageEnglish
Pages (from-to)273-276
Number of pages4
JournalStem Cell Research
Volume17
Issue number2
DOIs
StatePublished - Sep 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene'. Together they form a unique fingerprint.

Cite this